What is Titan Pharmaceuticals 6-1 Month Momentum %?
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-07), Titan Pharmaceuticals's 6-1 Month Momentum % is -20.35%.
The industry rank for Titan Pharmaceuticals's 6-1 Month Momentum % or its related term are showing as below:
TTNP's 6-1 Month Momentum % is ranked worse than 69.02% of 1517
companies
in the Biotechnology industry
Industry Median: -0.63
vs TTNP: -20.35
Competitive Comparison of Titan Pharmaceuticals's 6-1 Month Momentum %
For the Biotechnology subindustry, Titan Pharmaceuticals's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Titan Pharmaceuticals's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Titan Pharmaceuticals's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Titan Pharmaceuticals's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Titan Pharmaceuticals 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Titan Pharmaceuticals's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Titan Pharmaceuticals (Titan Pharmaceuticals) Business Description
Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TTNP has been successfully added to your